Biden's Patent Madness.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Rosen, Michael M.
  • Source:
    Commentary. Jun2021, Vol. 151 Issue 6, p24-27. 4p.
  • Additional Information
    • Subject Terms:
    • Abstract:
      The author comments on the decision of U.S. President Joe Biden's administration to waive global intellectual property protections for COVID-19 vaccines. Topics discussed include an argument by the Trade-Related Aspects of Intellectual Property Rights on relaxing patent rights for the medicines developed by pharmaceutical companies, the support of India to the announcement by TRIPS, and a problem with the World Trade Organization's on processing for authorizing general formulations of vaccines.